JSM 2012 Home

JSM 2012 Online Program

The views expressed here are those of the individual authors and not necessarily those of the JSM sponsors, their officers, or their staff.

Online Program Home

Abstract Details

Activity Number: 660
Type: Contributed
Date/Time: Thursday, August 2, 2012 : 10:30 AM to 12:20 PM
Sponsor: Biopharmaceutical Section
Abstract - #306166
Title: Single-Arm Phase IIA Clinical Trials with Go/No-Go Decisions
Author(s): Bob Zhong*+
Companies: Johnson & Johnson
Address: 1400 McKean Road, Spring House, PA, 19477, United States
Keywords: Phase IIA trials ; modified minimized two-stage designs ; asymmetric alpha spending

Phase IIA clinical trials are commonly conducted as pilot studies to evaluate efficacy and safety in selected populations of patients with the disease or condition to be treated or prevented. The efficacy objective is to find preliminarily evidence of the effectiveness or ineffectiveness of study treatments. Go/no-go decisions will be made during or at the end of these trials. Interim analyses (multiple stages) are usually built-in to terminate futile treatments. The designs presented in this paper match the efficacy objective with go/no-go decisions. This is achieved by setting up the threshold as the minimal effective response rate. Asymmetric type I error spending at this threshold is also possible. When two-stage designs are used, the stage I sample size is flexible and can cover all practical scenarios.

The address information is for the authors that have a + after their name.
Authors who are presenting talks have a * after their name.

Back to the full JSM 2012 program

2012 JSM Online Program Home

For information, contact jsm@amstat.org or phone (888) 231-3473.

If you have questions about the Continuing Education program, please contact the Education Department.